Get the Stockscreener App
1.53
4.08%
0.06
After Hours:
1.51
-0.02
-1.31%
Heartbeam Inc stock is traded at $1.53, with a volume of 2.95M.
It is up +4.08% in the last 24 hours and up +10.07% over the past month.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
See More
Previous Close:
$1.47
Open:
$1.65
24h Volume:
2.95M
Relative Volume:
0.25
Market Cap:
$61.38M
Revenue:
-
Net Income/Loss:
$-20.34M
P/E Ratio:
-2.1951
EPS:
-0.697
Net Cash Flow:
$-15.59M
1W Performance:
+4.79%
1M Performance:
+10.07%
6M Performance:
+9.29%
1Y Performance:
-24.63%
1-Day Range:
$1.51
$1.779
1-Week Range:
$1.42
$1.779
52-Week Range:
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Name
Heartbeam Inc
Sector
Industry
Phone
408-899-4443
Address
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.53 | 58.97M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-08-25 | Initiated | H.C. Wainwright | Buy |
| Oct-31-25 | Initiated | Roth Capital | Buy |
| Sep-11-20 | Initiated | Needham | Buy |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Aug-02-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-26-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-18 | Reiterated | Lake Street | Buy |
| Apr-26-18 | Reiterated | The Benchmark Company | Buy |
| Feb-23-18 | Reiterated | Dougherty & Company | Buy |
| Nov-08-17 | Reiterated | Dougherty & Company | Buy |
| Oct-26-17 | Initiated | Raymond James | Outperform |
| Oct-24-17 | Initiated | SunTrust | Buy |
| Aug-09-17 | Reiterated | Dougherty & Company | Buy |
| Jul-19-17 | Reiterated | The Benchmark Company | Buy |
| Apr-11-17 | Reiterated | Dougherty & Company | Buy |
| Dec-02-16 | Initiated | Dougherty & Company | Buy |
| Sep-13-16 | Initiated | Sidoti | Buy |
| Aug-03-16 | Reiterated | The Benchmark Company | Buy |
| Jul-28-15 | Reiterated | Dougherty & Company | Buy |
| Oct-24-13 | Initiated | The Benchmark Company | Buy |
| Aug-21-13 | Initiated | Dougherty & Company | Buy |
View All
Heartbeam Inc Stock (BEAT) Latest News
HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio - Digital Journal
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time - Business Wire
HeartBeam (BEAT) Announces Commercial Partnership With ClearCardio - Yahoo Finance
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target - Digital Journal
BEAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
HeartBeam (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform - Digital Journal
BEAT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HeartBeam (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year - Digital Journal
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - USA Today
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - USA Today
Risk On: Is SQNS stock a hidden gemMarket Sentiment Report & Daily Entry Point Alerts - baoquankhu1.vn
HeartBeam (BEAT) Price Target Increased by 16.22% to 5.48 - Nasdaq
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - USA Today
Breakout Move: What are HeartBeam Inc Equity Warrants recent SEC filings showingEarnings Growth Report & Smart Money Movement Alerts - baoquankhu1.vn
Will HeartBeam Inc. benefit from rising consumer demand2025 Trade Ideas & AI Forecasted Entry and Exit Points - mfd.ru
HeartBeam (BEAT) Showcased for Advancing Innovative ECG Platform - NewMediaWire
Will HeartBeam Inc. stock attract more institutional investorsWeekly Investment Summary & Smart Swing Trading Techniques - mfd.ru
HeartBeam’s Portable ECG Is Cleared, But Cash Is Tight - Finimize
HeartBeam Earns FDA Clearance for 12-Lead Synthesis Software for Assessing Arrhythmia - Diagnostic and Interventional Cardiology
Can HeartBeam Inc. stock deliver consistent earnings growth2025 Technical Overview & Technical Entry and Exit Alerts - mfd.ru
What is HeartBeam Inc.’s book value per shareTreasury Yields & Risk Managed Investment Strategies - mfd.ru
Why HeartBeam Inc. stock is considered a top pickJuly 2025 Institutional & High Accuracy Swing Entry Alerts - mfd.ru
BEAT Should I Buy - Intellectia AI
Jobs Data: Is HeartBeam Inc a turnaround storyPortfolio Update Report & Long-Term Investment Growth Plans - baoquankhu1.vn
HeartBeam (BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year - Yahoo Finance
Can HeartBeam Inc. outperform in the next rallyTrade Ideas & High Conviction Buy Zone Picks - mfd.ru
Is HeartBeam Inc. a strong candidate for buy and holdSwing Trade & Stepwise Entry and Exit Trade Signals - mfd.ru
What analysts say about HeartBeam Inc. stockJuly 2025 Weekly Recap & Real-Time Market Trend Scan - mfd.ru
Can HeartBeam Inc. Equity Warrant be recession proof2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - mfd.ru
HeartBeam (BEATW) Stock Analysis Report | Financials & Insights - Benzinga
HeartBeam Files $100 Million Mixed Shelf - marketscreener.com
Is HeartBeam Inc. Equity Warrant stock undervalued vs historical averagesWeekly Investment Recap & Real-Time Buy Signal Alerts - mfd.ru
Bryan Humbarger Named Chief Commercial Officer at HeartBeam - Medical Product Outsourcing
Aug Patterns: Can HeartBeam Inc deliver alpha2025 Price Momentum & High Return Trade Guides - baoquankhu1.vn
Market Recap: Does HeartBeam Inc Equity Warrant have pricing powerRecession Risk & Advanced Technical Signal Analysis - baoquankhu1.vn
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
Trend Review: Does HeartBeam Inc Equity Warrant have pricing power2025 Earnings Surprises & Detailed Earnings Play Alerts - baoquankhu1.vn
HeartBeam names Bryan Humbarger as CCO - Medical Buyer
US Market Wrap: How volatile is Empire State Realty OP LP Limited Partnership stockJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
HeartBeam appoints Bryan Humbarger as chief commercial officer By Investing.com - Investing.com Nigeria
HeartBeam (BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - NewMediaWire
Meme Stocks: Is CTGO on track to beat earningsTrend Reversal & Growth Focused Investment Plans - baoquankhu1.vn
Heartbeam, Inc. Appoints Bryan Humbarger as Chief Commercial Officer, Effective January 22, 2026 - marketscreener.com
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer - 01net
HeartBeam appoints Bryan Humbarger as chief commercial officer - Investing.com
Heartbeam Inc Stock (BEAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):